2022 CVM Updates

December

• December 23, 2022 - Department of Justice News - Collegeville Man Found Guilty for Scheme to Sell Fraudulent Canine Cancer-Curing Drugs to Pet Owners
• December 20, 2022 - FDA Approves First Injectable Pentosan for Osteoarthritis in Horses (Español)
• December 20, 2022 - FDA Issues Final Guidance on Best Practices for Convening a GRAS Panel
• December 19, 2022 - FDA and Federal Partners Issue Request for Information on the Regulation of Biotechnology
• December 17, 2022 - FDA Cautions Horse Owners Not to Feed Recalled Lots of Top of the Rockies Alfalfa Cubes due to Reports of Illness and Death (Español)
• December 16, 2022 - FDA Proposes Revisions to Guidance on Evaluating Safety of Antimicrobial Animal Drugs Based on Their Importance in Human Medicine
• December 14, 2022 - FDA Opens Registration for Virtual Public Meeting on FDA’s Role in the AAFCO Animal Feed Ingredient Definition Process
• December 13, 2022 - FDA Animal Drug Safety Communication: Micotil 300 Labeling Change (Español)
• December 13, 2022 - Updated - FDA Provides for More Treatments for Dogs and Cats to Qualify for Minor Use Status (Español)
• December 12, 2022 - FDA Releases Annual Summary Report on Antimicrobials Sold or Distributed in 2021 for Use in Food-Producing Animals (Español)
• December 9, 2022 - Department of Justice News - Thoroughbred Racehorse Trainer Jason Servis Pleads Guilty In Federal Doping Case
• December 8, 2022 - FDA Approves First Oral Treatment for Cats with Diabetes Mellitus (Español)
• December 7, 2022 - FDA Opens Second FY2023 Grant Funding Application Period for Animal Drugs for Minor Uses and Minor Species

November

• November 29, 2022 - FDA Announces Draft Guidance for Heartworm Disease Prevention Products for Dogs
• November 29, 2022 - FDA Launches Interactive Summary of Biomass-Adjusted Antimicrobial Sales Data in Food Animals (Español)
• November 18, 2022 - FDA Announces 2022 Public Meeting and Comment Period on Reauthorization of Animal Drug User Fee Program
• November 16, 2022 - FDA Releases Draft Amended Environmental Assessment for AquAdvantage Salmon and Announces Virtual Public Meeting
• November 16, 2022 - Department of Justice News - New York Veterinarian And Racehorse Trainers Sentenced To Prison In Federal Doping Case
• November 15, 2022 - FDA Conditionally Approves First Drug to Manage Acute Onset of Pancreatitis in Dogs

October

• October 20, 2022 - FDA Issues Final Guidance on Refusal of Inspection by a Foreign Food Establishment or Foreign Government
• October 19, 2022 - FDA Finalizes Guidance on Donor Eligibility and Manufacturing of Cellular Therapies for Animals (Español)
• Updated October 19, 2022 - FDA Announces 2022 Public Meeting and Comment Period on Reauthorization of Animal Generic Drug User Fee Program
• Updated October 18, 2022 - FDA Helps Improve Availability of Vetmedin, a Critical Heart Drug for Dogs, in the United States
• Updated October 18, 2022 - FDA Explains Revised Submission Process for U.S. Animal Feed Additive, Premix, and Compound Feed Facilities Interested in Exporting to China
• Updated October 12, 2022 - FDA Announces Virtual Listening Session on the Regulation of Animal Foods with Certain Types of Claims
• October 12, 2022 - FDA Announces 2022 Public Meeting and Comment Period on Reauthorization of Animal Generic Drug User Fee Program

September

• September 30, 2022 - FDA Reminds Human and Animal Food Facilities to Register or Renew Registration between October 1 and December 31, 2022
• September 29, 2022 - FDA Approves First Generic Spectinomycin Sulfate Injectable for Treatment of Bovine Respiratory Disease
• September 28, 2022 - FDA Approves Simplera Otic Solution to Treat Ear Infections in Dogs
• September 14, 2022 - FDA Provides for More Treatments for Dogs and Cats to Qualify for Minor Use Status
• September 8, 2022 - Department of Justice News - Horse Doping Seller Sentenced To 42 Months In Manhattan Federal Court
• September 7, 2022 - CVM Drug Safety Communication: Fluorouracil Products Used on People's Skin Can Cause Serious Reactions in Pets (Español)

August

• August 30, 2022 - FDA Announces Virtual Listening Session on the Regulation of Animal Foods with Certain Types of Claims
• August 11, 2022 - FDA Seeks Public Comment on Revised Guidance Documents Focused on Harmonizing Requirements for Anti-parasitic Drugs Used in Animals
• August 10, 2022 - FDA Releases FY 2020 Pesticide Residue Monitoring Report
• August 5, 2022 - FDA Cautions Pet Owners Not to Feed Certain Lots of Darwin’s Natural Pet Products Due to Salmonella
• August 1, 2022 - FDA Approves the First Generic Firocoxib Tablets for Horses (Español)

July

• July 29, 2022 - Department of Justice News - Illegal Pharmacy Operator Sentenced to Federal Prison
• July 27, 2022 - Department of Justice News - North Carolina Woman Pleads Guilty to Selling Unapproved Covid-19 Remedies
• July 27, 2022 - FDA Announces FY 2023 Animal Drug User Fee Rates for ADUFA and AGDUFA
• July 25, 2022 - FDA Withdraws Guidance on Indexing of Legally Marketed Unapproved New Animal Drugs for Minor Species (Español)
• July 22, 2022 - Food Facilities Invited to Join “How To” Webinar on Registration and Renewal as Biennial Food Facility Registration Period Approaches
• July 22, 2022 - FDA Details Optimized Approach for Regulatory Oversight Tools to Better Protect Public Health
• July 11, 2022 - Department of Justice News - Horse Doping Drug Supplier Sentenced To 11 Years In Prison
• July 6, 2022 - FDA Finalizes FSMA Guidance on Hazard Analysis and Preventive Controls for Animal Food
• July 5, 2022 - FDA Announces 2022 Public Meeting of the National Antimicrobial Resistance Monitoring System

June

• June 30, 2022 - FDA Delivers Progress Update on 5-Year Veterinary Stewardship Plan, Publishes Report about Antimicrobial Sales, Use, and Resistance Data in Animal Agriculture (Español)
• June 27, 2022 - FDA Announces Virtual Public Meeting on Advanced Manufacturing for Animal Drugs
• June 27, 2022 - FDA Announces Animal Biotechnology Webinar on Low-Risk Intentional Genomic Alterations in Animals for Food Use (Español)
• June 24, 2022 - FDA Recognizes JANAAC as an Accreditation Body Under FSMA- Accredited Third Party Certification Program
• June 22, 2022 - Department of Justice News - Amherst County Veterinarian Sentenced for Opioid Theft
• June 16, 2022 - FDA Conditionally Approves First Drug to Delay Onset of Congestive Heart Failure in Dogs (Español)
• June 10, 2022 - Updated - FDA Requests Public Comments on the Use of Antimicrobials in Companion Animals
• June 6, 2022 - FDA Announces Live Webinar on the Animal Drug Manufacturing System for Reporting Supply Chain Data
• June 6, 2022 - FDA Releases New Resource Page for Human and Animal Food Producers Affected by Flooding and Severe Weather Incidents

May

• May 31, 2022 - FDA Opens First FY2023 Grant Funding Application Period for Animal Drugs for Minor Uses and Minor Species
• May 26, 2022 - FDA Warns Four Companies for Illegally Selling CBD Products Intended for Use in Food-Producing Animals (Español)
• May 23, 2022 - FDA Shares New Report by Reagan-Udall Foundation on Establishing Public-Private Partnership to Collect and Analyze Antimicrobial Use Data from Food-Producing Animals
• May 11, 2022 - Department of Justice News - New York Racehorse Veterinarian And Standardbred Trainer Plead Guilty In Federal Doping Case
• May 9, 2022 - FDA Issues Draft Guidance that Consolidates and Updates Policies on Practices to Prevent Contamination of Animal Food from Unsafe Drug Carryover (Español)
• May 6, 2022 - Department of Justice News - Horse Doping Drug Seller Convicted In Manhattan Federal Court
• May 4, 2022 - FDA Issues Warning Letters to Companies Illegally Selling CBD and Delta-8 THC Products

April

• April 28, 2022 - FDA Issues the Accredited Third-Party Certification Program: Questions and Answers: Draft Guidance for Industry
• April 27, 2022 - FDA Issues Updated Guidance on Compliance and Date for Providing an Acceptable Unique Facility Identifier (DUNS number) for the Foreign Supplier Verification Programs
• April 26, 2022 - FDA alerts customers to voluntary recall of compounded drugs due to sterility issues by Drug Depot, LLC, dba APS Pharmacy
• April 21, 2022 - Department of Justice News - Lyndonville Woman Sentenced for Selling Misbranded Pet Medications
• April 20, 2022 - Department of Justice News - Supervisor at Long Island Drug Manufacturer Sentenced to Prison for Theft of Medical Products
• April 19, 2022 - FDA Releases NARMS Integrated Summary 2019 (Español)
• April 19, 2022 - FDA Announces Draft Guidance for the Use of Published Literature to Support New Animal Drug Approvals (Español)
• April 13, 2022 - FDA Issues Final Guidance on Animal Drug Compounding from Bulk Drug Substances

March

• March 30, 2022 - FDA Approves New Combination Drug for Sedation in Dogs (Español)
• March 30, 2022 - Updated - FDA Announces Public Hearing on Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox
• March 28, 2022 - Updated - FDA Advises Companies Regarding Inadvertent Presence of Low Levels of Certain Genetically Engineered Canola Seeds
• March 28, 2022 - FDA Approves the First Generic Firocoxib Chewable Tablets for Dogs (Español)
• March 28, 2022 - Department of Justice News - Operator of Portland Animal Rescue Business Charged for Role in Wire Fraud Conspiracy, Illegally Dispensing Animal Drugs
• March 28, 2022 - Federal judge enters consent decree against New Jersey raw animal food manufacturer
• March 28, 2022 - FDA Seeks $8.4 Billion to Further Investments in Critical Public Health Modernization, Core Food and Medical Product Safety Programs
• March 11, 2022 - FDA Issues Guidance on Enforcement Discretion Policies for Certain FSMA Regulations
• March 7, 2022 - FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review
• March 3, 2022 - Department of Justice News - Harness Trainer Christopher Oakes Sentenced To 3 Years In Federal Doping Case
• March 3, 2022 - FDA Urges Companies to be ’Recall Ready’ to Protect Public Health as Part of Final Guidance for Voluntary Recalls

February

• February 28, 2022 - FDA Veterinarians Contribute One Health Resource on Global Antiparasitic Resistance in Grazing Livestock (Español)
• February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States
• February 15, 2022 - FDA Requests Public Comments on the Use of Antimicrobials in Companion Animals (Español)
• February 2, 2022 - Department of Justice News - Horse Doping Drug Supplier Convicted In Manhattan Federal Court

January

• January 25, 2022 - FDA Approves First Generic Tilmicosin Phosphate Aqueous Concentrate for Swine (Español)
• January 24, 2022 - Department of Justice News - Former Veterinarian Pleads Guilty to Drug Charges
• January 21, 2022 - FDA Announces Two Veterinary Antimicrobial Stewardship Funding Opportunities for FY 2022 (Español)
• January 20, 2022 - FDA Approves First Transdermal Buprenorphine for the Control of Post-Surgical Pain in Cats (Español)
• January 13, 2022 - FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species
• January 12, 2022 - FDA Announces Public Hearing on Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox
• January 5, 2022 - Department of Justice News - Operator of Illegal Veterinary Pharmacy Pleads Guilty